Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Episurf Medical: First commercial case in the US scheduled

Episurf Medical (Nasdaq: EPIS B) today announces that the company’s first commercial case in the US has been scheduled for surgery. This is also the first case ever with the newly introduced product Episealer® Patellofemoral System. The product is a fully individualized implant system for patients with isolated osteoarthritis of the patellofemoral joint in the knee. Personalized implants for both sides of the joint, femur and patella, preserving as much bone and cartilage as possible by treating only the damaged areas of the joint, are designed uniquely for each individual patient. 510(k)

Half Year Report January – June 2023

A quarter with extensive preparatory work ahead of the definitive investment decision regarding Uddevalla.Q2 2023 · Net revenues for the period were MSEK 3.6 (1.9) · Earnings after tax for the period were MSEK -25.3 (-21.3) · Earnings per share for the period (before dilution) was SEK -0.03 (-0.03) · Cash flow for the period after investments was MSEK -27.0 (-25.8) · Enviro has successfully completed directed share issue of 150 million shares and raises proceeds of SEK 300 million · Enviro’s Chairman and CEO represent the company on the board of new joint venture ·

BioStock: Iconovo on the way to profitability

Iconovo, a leading developer of inhalation products, consolidates its financial targets for 2027 – revenues of 250 MSEK with an EBIDTA margin of 50 percent. Approximately 85 percent of the revenue is expected to come from projects that have already been initiated. In addition, the company expects to achieve profitability during one quarter as early as next year and 2025, as well as full-year profitability in 2026. BioStock contacted CEO Johan Wäborg to gain a deeper understanding of the company’s goals.Read the full article at biostock.se: https://www.biostock.se/en/2023/08/iconovo-on-

Bittium Corporation Continues to Develop Its Operations Towards Independent Business Units and Starts Change Negotiations

Bittium CorporationInside information Bittium Corporation Continues to Develop Its Operations Towards Independent Business Units and Starts Change Negotiations Bittium Corporation, Stock Exchange Release, August 23, 2023, at 9.00 am (CEST+1) Bittium Corporation has today decided to start change negotiations as part of measures to improve its profitability and develop its operations towards independent business units. The change negotiations concern all Bittium group’s subsidiaries in Finland, and the negotiations cover around 600 employees. The planned measures, if implemented,

First day to exercise Catena Media’s warrants (CTM TO1) for subscription of new shares during 14th exercise period

Catena Media plc today announces that the 14th period to subscribe for shares in the company by exercise of warrants (ticker CTM TO1) (“the warrants”) commences today, 23 August 2023, and will run until and including 1 September 2023. During this period, each warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 18.90. Payment of subscribed shares can be made in cash or through set-off with the full nominal amount of each hybrid capital security (ticker CATME HO1) that the warrant holder uses for set-off. The nominal amount of one (1)

Inify Laboratories - Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis

STOCKHOLM - August 23, 2023 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, successfully launched in the second quarter 2023.   “We launched our laboratory service in mid-June, completely according to plan. The interest is high, and we already see the first revenue streams,” says CEO Fredrik Palm at Inify Laboratories.   Since the opening, the response time – from the collection of samples until the customers have an electronically structured, easy-to-read report – has been well within the promised time.   “The secret

MEKO strengthens its focus on heavy vehicles through a new strategic collaboration

MEKO is expanding its efforts in heavy vehicles. Through a new strategic collaboration, MEKO becomes a supplier to Sweden's largest independent truck workshop chain, Malte Månson Verkstäder. The agreement further solidifies MEKO's position in Sweden while enabling Malte Månson Verkstäder to accelerate its expansion. "Heavy vehicles is one of MEKO's priority areas and one in which we are growing successfully. We have established operations in Norway, Finland, Sweden, and are on the verge of adding Denmark to the list. With this agreement, we are taking another important step as the

PRESS RELEASE – EMBARGOED 24 AUGUST 00.01(BST) Royal Meteorological Society Standard Chartered Weather Photographer of the Year 2023

Shortlist announced and public vote opens The Royal Meteorological Society is pleased to open the public vote for the 2023 Standard Chartered Weather Photographer of the Year competition. Now in its eighth year, the competition is a window to the vastly different climates experienced across the world and provides an international platform to highlight global weather events.The 2023 Standard Chartered Weather Photographer of the Year competition showcases some of the world’s most striking weather phenomena, alongside images that narrate compelling stories about the impacts of climate

SaltX Technology Holding AB Interim Report Q2 - 2023

SaltX Technology is a Swedish Greentech company that develops and markets sustainable technology that benefits customers, the climate, and society. The company today issues its Interim Report Q2 - 2023.“The second quarter of this year has consisted of pre-studies at industrial customer sites and planning for the world's first climate-neutral limestone factory together with SMA Mineral.”  - Carl-Johan Linér, CEO SaltX  Presentation of Interim report The report is presented in a video interview where SaltX CEO, Carl-Johan Linér, talks about the quarter that has passed, answers

Höegh LNG: Interim results for the quarter and half year ended 30 June 2023

Hamilton, Bermuda, 23 August 2023 - Höegh LNG Holdings Ltd. ("Höegh LNG") today reports its interim financial results for the quarter and half year ended 30 June 2023. The group reported a total income of USD 126.8 million and an EBITDA of USD 78.7 million for the second quarter of 2023, compared to USD 137.4 million and USD 91.9 million for the preceding quarter. Furthermore, during the quarter the group completed a new loan agreement for Hoegh Gandria and a new corporate credit facility.

InDex Pharmaceuticals Holding AB (publ) interim report January – June 2023

License agreement signed with Viatris Japan”We are thrilled to start our collaborative journey with Viatris Japan and work together to significantly improve the lives of patients suffering from ulcerative colitis,” said Jenny Sundqvist, CEO of InDex Pharmaceuticals. “Viatris Japan’s solid knowledge and presence in the gastroenterology therapy area will enable us to jointly maximize the potential of cobitolimod.” Period April – June 2023 · Net sales amounted to SEK 97.5 (0.0) million · Operating loss amounted to SEK 86.9 (–21.7) million · Result after tax amounted to SEK 90.0 (–

Quickbit launches Web App and Chrome extension – preparations for larger expansion

Today, Quickbit announces the launch of Quickbit App as a Web App and Chrome extension ("Add-On"). This means that Quickbit App's payment function becomes available in the browser and through a Chrome extension, which enables logging into a Quickbit account directly in the browser.The development of a Web App and Chrome extension is an important step in Quickbit's continued journey. This means an expansion of the existing ecosystem of products and services, while also preparing Quickbit for a larger expansion of its user base. Currently, Quickbit is preparing to take the step into

New publication shows the benefits of the GA-map® testing platform in Diabetes Type 2

OSLO, NORWAY – 23 August 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that a scientific article has recently been published in the medical journal BMC Endocrine Disorders, showing promising results of using microbiota as a tool for risk prediction of diabetes disease at an early stage. The article titled “EXPLORING THE GUT MICROBIOTA IN PATIENTS WITH PRE-DIABETES AND TREATMENT NAÏVE DIABETES TYPE 2 - A PILOT STUDY”, written by researchers at GA, demonstrates the strength of GA´s research portfolio and underlines the potential for expanding the use of the

Dividend Payment Update

Breukelen, 23 August 2023, 08.00 – TIE Kinetix, a leader in 100% supply chain digitalization provides an update on its dividend payment following financial close of the sale of its business and operations.On July 26, 2023 TIE Kinetix N.V., a leader in 100% supply chain digitalization, announced that it has reached agreement to sell all of its business and operations to SPS Commerce, Inc. for a total purchase price of € 68,35 million, subject to shareholder approval on an Extraordinary General Meeting, convened for September 6, 2023. Following financial close of the transaction, scheduled

Kesko acquires the Danish builders’ merchant Davidsen and enters Denmark

Kesko has agreed to acquire Davidsen Koncernen A/S, one of the largest builders’ merchants in Denmark. The acquisition marks Kesko’s first step into the Danish market and gives it a solid foothold in the local building materials market. It also further advances Kesko’s objective of strengthening its market position in Northern Europe. The Davidsen family will remain as a 10% minority shareholder in the company.Kesko continues to implement its growth strategy in Northern Europe, where it is a leading operator in building and technical trade. The Davidsen acquisition is Kesko’s first step

Continued streamlining yields results

With a continued focus on streamlining and product development, the Group’s operating activities deliver improved gross and EBITDA margins, despite declining order intake. This confirms once again that our chosen strategy is the right path for long-term profitable growth.Second quarter April–June Interim period January–June · Order intake amounted · Order intake amounted to MSEK 51.9 (82.5)to MSEK 20.5 (39.8) · Net sales amounted to MSEK 83.0 (74.0) · Net sales amounted to · Gross margin amounted to 70 (67) percentMSEK 44.7 (42.4) · EBITDA amounted to

Synergi releases one of the first electric vehicle solar charging services in Finland

In addition to EV smart charging and solar monitoring, Synergi’s smart electricity platform now supports EV solar charging and remote control of heat pumps. Solar charging could help customers charge their EVs for free.Helsinki (August 23, 2023) – Synergi , a Finnish technology company accelerating the transition toward sustainable energy sources with smart software solutions for consumers and businesses, announces it is extending its services for consumers to charge their electric vehicles with their solar power and remote control of heat pumps.  With

Interim report January- June 2023

Increased growth and stronger financial position April 1 - June 30, 2023 · Net sales increased 28 percent to SEK 4,292 M (3,357). Adjusted for the acquisition of Koivunen, net sales increased 12 percent. Organic growth was 9 percent. Net sales were positively impacted by currency effects of 3 percent. · EBIT amounted to SEK 304 M (185) and the EBIT margin was 6.8 percent (5.4). EBIT was positively impacted by items affecting comparability of SEK 59 M (-26) during the quarter. · Adjusted EBIT amounted to SEK 270 M (240) and the adjusted EBIT margin was 6.1 percent (7.0). ·

Devyser Diagnostics AB publishes quarterly report for the period April to June 2023

“The second quarter of the year saw an improvement in EBIT compared with recent quarters, continued high gross margins, strong growth and an exclusive collaboration and distribution agreement with US-based Thermo Fisher Scientific. Two new oncology products and one new transplant product were launched during the quarter. Our CLIA-certified laboratory in Atlanta was inaugurated and the first patient test was carried out in this laboratory.” Fredrik Alpsten, CEO, Devyser The quarter from April to June 2023 · Net sales amounted to SEK 37.7 million (30.9), corresponding to a 22.3%

Interim report 2 - 1 January - 30 June 2023 - New Value-Adding Partnership Agreements and Successful Integration of Wargraphs S.A.S.

Adjusted EBITDA increased by 160 percent compared to Q1 2023. Summary quarter 2 - 1 APRIL 2023 – 30 JUNE 2023 · Net sales amounted to SEK 63.7 million (SEK 70.8 million). · In the quarter, the company had costs linked to the acquisition of Wargraphs corresponding to SEK 5.4 million. · Adjusted EBITDA amounted to SEK 7 million (SEK 8.9 million). * · EBITDA amounted to SEK 1.6 million (SEK 8.9 million). · Operating profit amounted to SEK 0.1 million (SEK 7.7 million). · Profit before tax amounted to -4.5 MSEK (7 MSEK). · Cash flow from current operations before

QUARTERLY REPORT APRIL TO JUNE 2023

STRONG GROWTH - Q2 SAAS ARR +60% AND SAAS API CALL VOLUMES +117%APRIL TO JUNE 2023 · SaaS ARR amounted to 32.1 MSEK (20.0), +60% · SaaS API Call Volumes 20.2 million (9.3), +117 % · Total ARR amounted to 61.1 MSEK (38.9), +57% · Recurring revenues amounted to 14.6 MSEK (9.1), + 60% · Net sales amounted to 14.8 MSEK (10.2), + 45% · Gross margin (*) amounted to 72% (55) · EBITDA adjusted amounted to -13.9 MSEK (-20.6) · Earnings per share amounted to -0.2 SEK (-2.4) JANUARY TO JUNE 2023 · SaaS ARR amounted to 32.1 MSEK (20.0), +60% · SaaS API Call Volumes

Scandi Standards AB (publ) interim report January - June 2023

Continued earnings improvement   April – June 2023 · Net sales amounted to MSEK 3,411 (3,056) in the second quarter of 2023. At constant exchange rates net sales increased by 7 per cent. · Operating income (EBIT) increased to MSEK 121 (42), corresponding to a margin of 3.5 (1.4) per cent. · Income for the period amounted to MSEK 74 (7). Earnings per share amounted to SEK 1.11 (0.07). · Operating cash flow was MSEK 272 (135).   January – June 2023 · Net sales amounted to MSEK 6,695 (5,848) in the first half of 2023. At constant exchange rates net sales

Inside Information: Solteq Plc to initiate change negotiations to improve operational efficiencies and profitability

Solteq PlcInside InformationAugust 23, 2023, at 08:02 a.m.Solteq Plc initiates change negotiations under Chapter 3, Section 16 of the Co-operation Act for the Utilities business segment. The change negotiations will take place to restructure the organization and improve the business's profitability. In January-June 2023, the Utilities segment’s operating result was EUR -2.8 million. The improvements to operational efficiencies target total annual savings of approximately EUR 3 million.  ”The Utilities business area has had long-standing problems with product quality and development

BerGenBio Reports Second Quarter 2023 Financial Results

BERGEN, Norway, August 23, 2023 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced financial results for the second quarter and first half ended June 30, 2023, and provided a business update. A briefing by BerGenBio's senior management team will take place at 10:45 am CEST today via a webcast presentation, followed by a Q&A session. Please see below for details.   "For the second quarter we are pleased to report the outcomes of our cost-savings efforts and the

There are no items matching the current filter
There are no more items matching the current filter
Back to top